The department or self-insurer may pay for adjuvant treatment to aid with the weaning (see WAC 296-20-03030 for the definition of step 1 and 2 taper) or detoxification process, except for ultra-rapid detoxification (e.g., detoxification within three days using antagonist drugs with or without sedation). The department or self-insurer is not responsible for any adverse outcomes resulting from continued opioid use after completion of a detoxification program.